Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial - Wikidata - awgldk - TriplyDB

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

http://www.wikidata.org/entity/Q37196970

about

Genomic analysis to guide choice of treatment for smoking cessation Nicotine replacement therapy for smoking cessation Interventions for preventing weight gain after smoking cessation Achieving smoke-free mental health services: lessons from the past decade of implementation research Clarity and strength of implications for practice in medical journal articles: an exploratory analysis Pharmacologic agents for tobacco dependence treatment: 2011 update.The association between changes in alternative reinforcers and short-term smoking cessation.Chronic disease management for tobacco dependence: a randomized, controlled trial Strategies to help a smoker who is struggling to quit Prevalence of NRT use and associated nicotine intake in smokers, recent ex-smokers and longer-term ex-smokers.A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.National cancer institute conference on treating tobacco dependence at cancer centers.Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers Combination pharmacotherapy for stopping smoking: what advantages does it offer?Statistical analysis of daily smoking status in smoking cessation clinical trials.Long-term nicotine replacement therapy: a randomized clinical trial.Randomized trial of four financial-incentive programs for smoking cessation Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation.Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.Enhancing the effectiveness of smoking treatment research: conceptual bases and progress.Comparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment.Identifying effective intervention components for smoking cessation: a factorial screening experiment.High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessation.Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.Is a cancer diagnosis a teachable moment for the patient's relative who smokes?The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence.A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.Smoking cessation-recent advances.Interventions for tobacco smoking.The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.Qualitative exploration of a smoking cessation trial for people living with HIV in South Africa.Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?Pilot evaluation of a brief intervention to improve nicotine patch adherence among smokers living with HIV/AIDS.Prevalence and Impact of Long-term Use of Nicotine Replacement Therapy in UK Stop-Smoking Services: Findings From the ELONS Study.The use of varenicline to treat nicotine dependence among patients with cancer.

P2860

Q24188234-89AEFFE1-0F41-4194-820B-CBA6DDC79077 Q24202991-6C3FD617-2B33-4F3B-B11B-DB994EC736E6 Q24203883-9CA74397-9E3B-4B4F-9EC0-3CA96DB38B39 Q26825568-AEC62367-C7FD-4AE1-983A-E7763DEAEB49 Q28387287-5EB63270-FBD1-45F5-9285-8DB6DC1BFC86 Q30408254-F002AA5E-7900-4A63-8D20-10C86E5A88E9 Q33648645-42C3C424-5B66-46DB-AC51-232E5F99C5F5 Q33949648-3F0E9ABB-90AB-46B9-9B45-508F8DD931A3 Q34306544-8EA78417-3951-4280-B239-FF0BB07A42A1 Q34535880-35C23303-4CAE-46C8-A572-4B99A48907EA Q34570684-CCE4D0E6-CA96-4457-9B4D-CE18E718FAE8 Q34974916-0A5D3B37-9AD5-4F83-A15B-19AF7A1073D5 Q35012346-CFC11FE9-C45C-4879-B2B6-DF9C60ECC22E Q35188753-73B397E2-837D-43F1-8715-38CC2F283E53 Q35393403-7052D12F-F513-401B-B123-17659D6CB67D Q35541820-DAB86670-EC40-45BA-B10E-5F988E175F02 Q35754784-3CD1806A-374F-4A39-8FBA-88FEBEEA5854 Q35782141-D1B0A0BC-1179-4AE0-A55D-450D2B57597E Q35785818-4F2FD9E2-C358-41DE-BFE0-7410B27666D4 Q35982244-8D6C9AE8-1F1C-4B1A-994E-EBC222F6F227 Q36021256-FD59D773-4700-48B0-A46D-D8D7AB9E3087 Q36377987-87A472F7-4605-4EBB-AE55-3550877A4077 Q36407461-E3FDDB3F-4D7B-4FB1-868F-DBFB51BBEB55 Q36424667-9C76DA91-34C8-404B-84D4-B7A089B9E36C Q36534993-A9BF086F-A543-48A4-BB5B-8DAB3817417D Q36703942-82B4C20D-0CC8-4A4E-B7CE-F0935CE2B0E1 Q36868963-5048180B-3946-4E5A-80F8-E91956C20067 Q36913241-11E15461-2141-4A48-8F60-425C51735F28 Q37079969-DC1D4791-53FB-4FEF-970E-D38DB10D2430 Q37395553-5472FC8D-5623-4905-B3C0-7BE08910E113 Q37424588-D8951161-56A1-43D9-BF2D-269C165582DF Q37497939-40D11F6A-0868-42D9-B14F-A19D5CC6D1A4 Q37770073-C9C931BC-39C3-498B-B7AE-BCFFE71C96F1 Q38072454-43A92F0C-6E20-4C0F-B14E-867E8022CEEA Q38254067-7D143149-A1BD-4969-A04D-A476587652A7 Q38668397-E2D6744F-CB65-4281-9AD2-D2EE75E36AA2 Q38758931-D618DBB8-DC1C-48BE-A9C7-9AB655ADC022 Q38804759-5A2C1D1E-8B94-4BFE-8238-7B1847C281AC Q39354529-5F545D03-DC02-418E-8FAF-DF0EEAA464FD Q39740632-34AACB04-9A09-45B5-80E4-E262380D69C3

P2860

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

http://www.wikidata.org/entity/Q37196970

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

@en

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.

@nl

type

label

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

@en

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.

@nl

prefLabel

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

@en

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.

@nl

P1433

Q37196970-63CC7B9C-3075-4F38-B1F9-9AD0656B8BFA

P1476

Q37196970-E24BCF09-4AB3-4E8A-952B-95EA06E3E46C

P2093

Q37196970-3CBE5AF9-788F-4A0C-8D17-4A07B1CF24CA

Q37196970-64D69FF4-B1BD-4E91-A458-076AD86B5BF5

Q37196970-B7227280-61FC-49E8-81E1-E87603F133D5

Q37196970-F027701A-A6BB-45B9-8926-9F0F39FFF914

Q37196970-FDEE7E02-ECEC-47F8-B12E-D9B2CF8DAE7A

P2860

Q37196970-0A8D7A51-511B-4E09-AA24-3BEC9501E406

Q37196970-10BF4C0C-1BE9-4882-BB9B-F8BFC7006509

Q37196970-15A8EA87-F287-481F-B1C8-3C07E374C469

Q37196970-1F2ED7A4-397B-4377-A277-7D49ABFEEABE

Q37196970-20AF5DA1-4783-45BE-8914-856B029BF97E

Q37196970-2560C19E-AA63-48CE-9663-888F53D50040

Q37196970-25A1C6FF-D550-4E95-A176-9FB9279F4505

Q37196970-2741CA38-3F70-4656-99DC-905BD71B3F88

Q37196970-2FF5537D-143B-47DB-B889-F9B5175C393A

Q37196970-3A01BC5F-8287-4D20-8B56-8A5F7884D49D

P304

Q37196970-6D158316-47C8-42AB-84F6-0C9BEA7FDB6F

P31

Q37196970-173E0AFE-C412-4A75-8D8D-1795D312C72D

P356

Q37196970-3E78FC0B-6233-4F2E-B9C8-C134807A0D31

P407

Q37196970-C04EFF0C-03F2-4262-B2B1-8A0A7109F037

P433

Q37196970-5712679C-A91F-4575-B3A2-04882EDFA38A

P478

Q37196970-07C1A434-4545-42A6-9E55-2EF67247F91A

P50

Q37196970-92EBDA5D-8910-4498-8954-E4207C0D5331

Q37196970-FD53942A-352B-4EF3-9C3A-0DE98F639125

P577

Q37196970-09CD7295-21E5-4213-9FD5-9FF3443729D1

P698

Q37196970-3203C86A-DBE4-4546-A177-14D51A8E5C86

P932

Q37196970-B3CC3E07-DC7B-4038-9D81-6D09C54E95E4

P356

0003-4819-152-3-201002020-00005

P1433

Annals of Internal Medicine

P1476

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

@en

P2093

Alexandra E Shields

http://www.w3.org/2001/XMLSchema#string

Daniel F Heitjan

http://www.w3.org/2001/XMLSchema#string

E Paul Wileyto

http://www.w3.org/2001/XMLSchema#string

Freda Patterson

http://www.w3.org/2001/XMLSchema#string

Robert A Schnoll

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotine replacement therapy for smoking cessation

Antidepressants for smoking cessation

Addressing tobacco in managed care: results of the 2002 survey.

Tobacco withdrawal in self-quitters

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

A note on robust variance estimation for cluster-correlated data.

Fieller's method and net health benefits.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Natural history of nicotine withdrawal.

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.

P304

144-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-152-3-201002020-00005

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20124230

http://www.w3.org/2001/XMLSchema#string

P932

3782858

http://www.w3.org/2001/XMLSchema#string